Jco Precision Oncology

Journal Title：Jco Precision Oncology

JCO PO is a peer-reviewed, online-only, article-based journal publishing original research, reports, opinions, and reviews that advance the science and practice of precision oncology and define genomics- and other biomarker-driven clinical care of patients with cancer. Innovative and timely scientific and educational content provide a deeper understanding of actionable cancer genomics, personalized translational and clinical oncology research, and recent treatment advances based on tumor molecular profiling. The scope of publications includes all types of clinical research (basket trials, exceptional response results, informatics, computational approaches, mechanism and evidence-based case reports and small series of educational value), and extensive expert driven commentary, editorials and reviews considering the challenges and value of targeted therapies based on genomic analyses. JCO PO is published by the American Society of Clinical Oncology (ASCO).

JCO PO 是一本同行评审的在线文章型期刊，发表原创研究、报告、观点和评论，推动精准肿瘤学的科学和实践，并定义癌症患者的基因组学和其他生物标志物驱动的临床护理。创新且及时的科学和教育内容提供了对可操作的癌症基因组学、个性化转化和临床肿瘤学研究以及基于肿瘤分子分析的最新治疗进展的更深入了解。出版物范围包括所有类型的临床研究（篮子试验、特殊反应结果、信息学、计算方法、机制和循证病例报告以及具有教育价值的小系列），以及大量专家驱动的评论、社论和评论，考虑到基于基因组分析的靶向治疗的挑战和价值。 JCO PO 由美国临床肿瘤学会 (ASCO) 出版。

Jco Precision Oncology由LIPPINCOTT WILLIAMS & WILKINS出版商出版，收稿方向涵盖ONCOLOGY全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 ，影响因子指数5.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。